2011•Shiyong yixue zazhiRequires access

Study on effects of naproxen on the proliferation and apoptosis of human cervical cancer Hela cells in vitro

Liu Y

Open publisher page 0 citations

Abstract

Objective To investigate the effect of naproxen on proliferation and apoptosis of human cervical cancer Hela cells in vitro. Methods Hela cells were treated with different concentration of naproxen (1 μg/mL; 10 μg/mL; 100 μg/mL; 300 μg/mL; 500 μg/mL), at different times (6,12,24,48 h). Cell viability was determined by MTT assay; Cell morphology was examined by fluorescent microscope, in which cells were treated with 500 μg/mL naproxen for 48 h. Cell apoptosis was analysed by flow cytometry with Annexin V-FITC/PI staining. Results 1.MTT assay indicated that different concentration of naproxen can inhibit the proliferation of Hela cells (P 0.01) 2. In cell morphology assay, condensed cell nucleus andapoptotic-body could be observed. 3. Apoptosis rate of Hela cells were significantly increased after treated by naproxen. Conclusion Naproxen can inhibit the proliferation of cervical cancer Hela cells and induce apoptosis in vitro in a dose-dependent and time-dependent manner.

About this research paper

What this paper is about

Objective To investigate the effect of naproxen on proliferation and apoptosis of human cervical cancer Hela cells in vitro. Methods Hela cells were treated with different concentration of naproxen (1 μg/mL; 10 μg/mL; 100 μg/mL; 300 μg/mL; 500 μg/mL), at different times (6,12,24,48 h). Cell viability was determined by MTT assay; Cell morphology was examined by fluorescent microscope, in which cells were treated with 500 μg/mL naproxen for 48 h. Cell apoptosis was analysed by flow cytometry with Annexin V-FITC/PI staining. Results 1.MTT assay indicated that different concentration of naproxen can inhibit the proliferation of Hela cells (P 0.01) 2. In cell morphology assay, condensed cell nucleus andapoptotic-body could be observed. 3. Apoptosis rate of Hela cells were significantly increased after treated by naproxen. Conclusion Naproxen can inhibit the proliferation of cervical cancer Hela cells and induce apoptosis in vitro in a dose-dependent and time-dependent manner.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of naproxen on proliferation and apoptosis of human cervical cancer Hela cells in vitro. Methods Hela cells were treated with different concentration of naproxen (1 μg/mL; 10 μg/mL; 100 μg/mL; 300 μg/mL; 500 μg/mL), at different times (6,12,24,48 h). Cell viability was determined by MTT assay; Cell morphology was examined by fluorescent microscope, in which cells were treated with 500 μg/mL naproxen for 48 h. Cell apoptosis was analysed by flow cytometry with Annexin V-FITC/PI staining. Results 1.MTT assay indicated that different concentration of naproxen can inhibit the proliferation of Hela cells (P 0.01) 2. In cell morphology assay, condensed cell nucleus andapoptotic-body could be observed. 3. Apoptosis rate of Hela cells were significantly increased after treated by naproxen. Conclusion Naproxen can inhibit the proliferation of cervical cancer Hela cells and induce apoptosis in vitro in a dose-dependent and time-dependent manner.

Key concepts: HeLa, Apoptosis, Annexin, MTT assay, Flow cytometry, In vitro, Viability assay, Naproxen

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on effects of naproxen on the proliferation and apoptosis of human cervical cancer Hela cells in vitro — Research Paper | ScholarLens